🇺🇸 FDA
Pipeline program

ELX-02

EL-004

Phase 2 small_molecule completed

Quick answer

ELX-02 for Cystic Fibrosis is a Phase 2 program (small_molecule) at Eloxx Pharmaceuticals with 2 ClinicalTrials.gov record(s).

Program details

Company
Eloxx Pharmaceuticals
Indication
Cystic Fibrosis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials